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ABSTRACT
Computed tomography (CT) imagery is an important weapon in the fight against lung
cancer; various forms of lung cancer are routinely diagnosed from CT imagery. The growth of the
suspect nodule is known to be a prognostic factor in the diagnosis of pulmonary cancer, but the
change in other aspects of the nodule, such as its aspect ratio, density, spiculation, or other features
usable for machine learning, may also provide prognostic information.
We hypothesized that adding combined feature information from multiple CT image sets
separated in time could provide a more accurate determination of nodule malignancy. To this end,
we combined data from multiple CT images for individual patients taken from the National Lung
Screening Trial. The resulting dataset was compared to equivalent datasets featuring single CT
images for each patient. Feature reduction and normalization was performed as is standard.
The highest accuracy achieved was 83.71% on a subset of features chosen by a combination of
manual feature stability testing and the Correlation-based Feature Selection algorithm and classified
by the Random Forests algorithm. The highest accuracy achieved with individual CT images was
81.00%, on a feature set consisting solely of the volume of the nodule in cubic centimeters.
iii
CHAPTER 1
INTRODUCTION
By definition, cancer involves the uncontrolled division of cells, and by extension, the un-
controlled growth of tissues in the body. It stands to reason, then, that if we derive features from
images of cancerous growths, the change in those features over time could be important. Changes
in features over time could indicate malignancy more accurately than would the features at any
single point in time.
Lung cancer is responsible for more deaths per year in the United States than any other form
of cancer [1]. Typically, lung cancer is preceded by the development of pulmonary nodules, which
can be detected with low-dose CT imagery. The ability of low-dose CT scans to detect pulmonary
nodules was demonstrated via the National Lung Screening Trial (NLST) [24]. However, these
nodules are frequently benign, and determining which nodules are malignant and which are benign
is challenging at best.
There are many image features that have been developed by various researchers over the
years with the intent of finding one or several that are indicative of malignancy. [2][27][18] These
features can generally be grouped into three categories: shape features, or features derived from the
shape of the nodule (as segmented either by a radiologist or by an automated process such as that
developed by Dr. Yuhua Gu et al. [15]); intensity features, or features derived from the intensity
of the pixels or voxels within the segmented nodule; and texture features, or features derived from
the internal texture of the nodule or potentially the tissue immediately surrounding it.
Thus far, the overwhelming majority of features have been based on the images from a
single CT scan. Studies have been performed on images from scans performed a matter of minutes
apart, but these features are used primarily to determine the stability of the computed features,
rather than reveal information about the nodules themselves [2][3].
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An alternative is to combine features from multiple scans, taken months or years apart,
to get a more informed idea of whether the nodule is changing (hence likely to be considered
malignant) or static (more likely to be benign).
There are two primary approaches to be taken here. The first is to use the same features
from two (or more) scans taken a significant time apart, and rely on the classifier to determine the
connection between each pair of columns. Another is to create new features by taking the difference
between the values in each feature for each pair of scans and using it as a new feature to be fed
into the feature selection and classification pipeline.
The goal of this research is to determine whether this approach is feasible, and how much of
an improvement (if any) the additional information provides. Some small but statistically significant
improvement was found.
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CHAPTER 2
RELATED WORK
2.1 Radiomics
According to Lambin et al.,
“The underlying hypothesis of Radiomics is that advanced image analysis on conven-
tional and novel medical imaging [sic] could capture additional information not currently
used, and more specifically, that genomic and proteomics patterns can be expressed in
terms of macroscopic image-based features.” (p. 3) [23]
The authors point out that medical imaging has improved in four distinct ways:
1. Improved hardware: from the early days of X-ray imaging, researchers have moved to
single-slice computed tomography (CT) imagery, and from there to multiple-slice CT and
combined CT and positron emission tomography (CT/PET). Magnetic resonance imag-
ing (MRI) scans are also used. The resolution has also improved significantly, allowing
researchers to see with more and more detail the contents of suspicious regions in the body.
2. Improved image agents: contrast agents can be used to highlight the regions of the body
that are of interest, by tracing blood flow or substance absorption.
3. Improved standardization: “Historically, radiology has been a qualitiative science”, writes
Lambin, indicating previous reliance on human interpretation of radiological imagery (and
the ad-hoc nature of much of the imagery collection process). Recently, there has been a
trend toward standardized protocols, making radiology more reproducible and the collected
imagery usable across individual cases (or locations).
3
4. Improved analysis: given the previous improvements, computer-aided detection (CAD) sys-
tems have improved as well, with advanced algorithms giving more details about detected
regions.
A search of the literature has found the papers listed in Table 2.1.
2.1.1 Feature Extraction
Extraction of features from a CT image is a process with several steps.
The first step (after identification of a nodule, which must still, as of this writing, be
performed by humans1) is nodule segmentation, or separating the nodule from its environment.
This is often done automatically, but with a human verifying results. For instance, Dr. Yuhua Gu,
et al., introduced an algorithm to segment a nodule [15], which combines a relatively straightforward
region-growing algorithm with a clever iteration process.
Extraction of features from segmented lung nodule imagery is the realm of software packages
such as Definiens Lung Tumor Analysis (LuTA) and 3D Slicer [13]. Features are continually being
developed; Dhara et al. list several dozen features, some of which were unavailable at the time of
the experiments discussed in Chapter 3 [9].
Generally, the segmented nodule is analyzed in isolation, but some work has been done on
including other parts of the imagery. For instance, Dilger et al. include a portion of the parenchyma
and obtain an AUC measure of 0.938 when distinguishing malignant from benign nodules, versus
0.918 using only the segmented nodule [10].
2.1.2 Feature Selection/Dimensionality Reduction
One issue that appears to be common in radiomics is the relatively small size of the data set
on which classifiers are trained. Any given data set may only have a few dozen or a couple hundred
patients, due to the difficulty of obtaining informed consent from patients and the relative rarity of
certain forms of cancer. At the same time, image processing suites such as Definiens can generate
hundreds of features based on Laws texture masks and wavelet decomposition; see Appendix A for
1Deep learning methods may be able to take over the nodule identification role, but as of the time of this writing,
they are not able to do so with anything resembling reliability.
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an example. Therefore, it is nearly mandatory that some form of feature selection or extraction be
employed to reduce the dimensionality of the feature set.
Feature selection is an active area of research, with a goal of keeping the features that
inform the classification while rejecting the ones that are irrelevant or redundant. Fundamentally,
the better the correlation between the selected features and the class, the better the feature selection
algorithm can be considered to be.
A classic example of a ranking feature selection algorithm is Relief, introduced in 1992 by
Kenji Kira and Larry Rendell [20]. It was extended in 1994 by Igor Kononenko into six variants,
labeled ”Relief-A” through ”Relief-F”. The last of these variants is among the best-known feature
selection algorithms; it extends the original Relief algorithm to support classification problems with
more than two classes.
The LASSO operator, introduced in 1996 by Robert Tibshirani, performs both feature
selection and data normalization on the input data [28]. LASSO is a refinement of the Nonnegative
Garotte, introduced by Leo Breiman in 1995 [4].
Tools such as Principal Component Analysis, Independent Component Analysis, or Linear
Discriminant Analysis have been used to combine the hundreds or thousands of features into a few
that express most of the information in the original feature set.
2.1.2.1 Dimensionality Reduction of High-Dimensionality Data
Typically, feature selection is intended for data sets with high, but not extremely high,
feature counts. As mentioned, a typical radiomic dataset may include only several dozen patients,
but several hundred individual features. Genetic data sets are even more difficult, as the number
of features may number in the millions (and, needless to say, even the largest data sets will only
have a few thousand patients). The problem of sifting through these millions of features to find the
ones that are most informative has grown alongside the preeminence of datasets that would require
such algorithms.
For high-dimensional data, algorithms such as least-angle regression (LARS) show some
promise. LARS, introduced by Efron et al. in 2004, is a refinement of the venerable stepwise
regression algorithm; its authors assert that it is suitable for cases where p >> n. LARS is a
generalization of both the LASSO and Forward Stagewise linear regression.
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However, LARS suffers when features are correlated, which is increasingly likely with in-
creasing dimensionality; this makes LARS’ utility for high-dimensional data more limited without
significant preprocessing.
2.1.3 Data Synthesis
Another approach to dealing with the paucity of data is to generate synthetic training data.
For instance, the SMOTE algorithm [8] can be run on an existing training set to generate additional
elements to train on, by taking existing elements pairwise and generating a new element somewhere
“between” the two: taking the two elements as points in N-dimensional space, the algorithm creates
a synthetic element somewhere on the line segment between those points.
2.1.4 Classification
Classic classification algorithms such as na¨ıve Bayes, decision trees (e.g. C4.5), and support
vector machines [7] continue to be the workhorses of the radiomics classification problem. However,
new approaches are being developed.
Kuruvilla and Gunavathi applied neural networks to the classification problem in 2014 [22].
Using feed-forward and back-propagation networks along with statistical features derived from the
entirety of the lung field, they claim to have a 93.3% accuracy in detecting lung cancer.
2.2 Time-Differential Features
As of the time of writing, the attempt to use time-differential features alongside radiomic
techniques seems to be a fairly small niche. Few papers have discussed it, and none of those have
been in the context of diagnosis. Instead, the only papers that have done so have been addressing
prognosis of confirmed cancer cases based on changes due to treatment.
The idea of using multiple readings to extract additional information from a series of radio-
graphic images appears to originate at least as far back as 2005, when Hoekstra et al. compared
[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography (18FDG-PET) before and during
induction chemotherapy (IC) [17]. Across 47 patients, the rate of change in the metabolic rate of
glucose (rate of glucose consumption) showed prognostic value, with a hazard ratio of 1.95.
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Van Elmpt et al. took 18FDG-PET/CT scans of 34 non-small-cell lung cancer patients
before radiotherapy began, and again during the second week of radiotherapy, measuring the CT
volume and the standardized uptake value parameters. [29]
Carvalho et al. examine the use of delta radiomics with 18FDG-PET exams, using it to
predict the outcome of treatment. Specifically, the authors examined 18FDG-PET scans taken
before and during the second week of radiotherapy to predict survival rate. Model creation was
performed on a set of 54 patients, and verification was performed on a set of 58 patients ranging
from stage IIa to IIIb. Features included both shape and texture features, limited to those with
sufficiently high intra-class correlation (ICC) on both test-retest and interobserver stability analysis
(IOSA), and further reduced with the LASSO method. With this model, the authors obtained a C
statistic (area under the ROC curve) of 0.58-0.61. [6]
Another group that has experimented with time-differential features is Fave et al.; their
experiment is similar in nature to Carvalho’s. They computed 62 features for each of 107 pa-
tients, including both shape and texture features, and then compared to dose fraction to determine
correlation. Models were computed using leave-one-out verification, both for clinical-features-only
and clinical-plus-delta-radiomics-features input sets, and for local-recurrence, distant-metastases,
and overall-survival. For overall-survival, the addition of delta-radiomics features improved the
C statistic from 0.52 to 0.62; for distant metastases it improved from 0.53 to 0.58, and did not
improve at all for local-recurrence. Autocorrelation, kurtosis, and compactness were the features
most commonly selected in the delta-radiomics form. [12]
7
Table 2.1 Existing literature.
Author Title
Year Description
National Lung Screening Re-
search Team
Reduced Lung-Cancer Mortality with Low-Dose Computed
Tomographic Screening
2011 The National Lung Screening Trial was conducted to deter-
mine whether low-dose CT imagery was at least as effective
as classic X-ray imagery at detecting lung cancer at an early
stage, with screenings performed on 53,454 patients at high
risk of lung cancer (each patient having a history of more
than 30 pack-years of smoking). The patients undergoing
screening CT exams had a mortality rate of 247 deaths per
100,000 person-years, compared to 309 deaths per 100,000
person-years for the X-ray patients, or a 20.0% reduction
in mortality for the CT patients. Overall rate of death for
the CT group was reduced by 6.7% compared to the X-ray
group. This clearly shows that screening via low-dose CT
reduces mortality due to lung cancer.
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Table 2.1 (Continued)
Author Title
Year Description
Gu et al. Automated delineation of lung tumors from CT images us-
ing a single click ensemble segmentation approach
2013 Dr. Gu et al. introduce a technique used in our analysis.
Using an ensemble of automated segmentation algorithm
runs with varying start points, the “single click ensemble
segmentation” algorithm finds a stable and accurate seg-
mentation for a given lung nodule, given only a single start-
ing point (hence the name). This is beneficial for low-dose
CT imagery, as borders are more difficult to ascertain au-
tomatically, and small variations in the border can result in
disproportionate variations in the computed features, lead-
ing to varying results.
Lambin et al. Radiomics: Extracting more information from medical im-
ages using advanced feature analysis
2012 This paper introduces the concept of radiomics. The au-
thors cover the fundamental differences between radiomic
approaches and others: primarily, the hypothesis that ge-
nomic and/or proteomic data can be inferred from imagery,
and using the heterogeneity of the analyzed masses for ad-
ditional predictive power.
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Table 2.1 (Continued)
Author Title
Year Description
Fried et al. Stage III Non–Small Cell Lung Cancer: Prognostic Value of
FDG PET Quantitative Imaging Features Combined with
Clinical Prognostic Factors
2016 The authors use 18FDG-PET imagery to determine prog-
nosis after treatment for NSCLC patients undergoing radi-
ation treatment.
Kuruvilla and Gunavathi Lung cancer classification using neural networks for CT im-
ages
2014 In this report, the authors use CT imagery passed into neu-
ral networks to determine malignancy of nodules. Using
these networks, an accuracy of 93.3% was obtained. It
stands to reason that these results can be further improved
by introducing change descriptors into the analysis, but this
will have to be a subject for further study.
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Table 2.1 (Continued)
Author Title
Year Description
Hoekstra et al. Prognostic Relevance of Response Evaluation Using [18F]-2-
Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography
in Patients With Locally Advanced Non-Small-Cell Lung
Cancer
2005 This is an early attempt at using change in tumors for ad-
ditional data. Where our research was conducted with the
goal of determining malignancy of nodules of unknown sta-
tus, the authors of this paper focused their research on eval-
uation of radiation therapy on known-malignant tumors.
Also, instead of CT imagery, the authors used 18FDG-PET
scans for source imagery. The only feature analyzed was
the volume of each tumor.
Carvalho et al. Early variation of FDG-PET radiomics features in NSCLC
is related to overall survival - the “delta radiomics” concept
2016 Here we find an early mention of “delta radiomics”. As with
Hoekstra et al., the authors use 18FDG-PET imagery in-
stead of CT images, and focus entirely on treatment efficacy
rather than diagnosis. The concepts are present, though.
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Table 2.1 (Continued)
Author Title
Year Description
Fave et al. TU-D-207B-02: Delta-Radiomics: The Prognostic Value of
Therapy-Induced Changes in Radiomics Features for Stage
III Non-Small Cell Lung Cancer Patients
2016 In this study, the authors use delta-radiomics features in
CT images to improve prognostic predictions for patients
with Stage III non-small-cell lung cancer (NSCLC). This
is, again, focused primarily on the evaluation of treatment
efficacy rather than prediction of malignancy. The addition
of delta-radiomics features improved the C-index of overall
survival prediction from 0.52 to 0.62, with corresponding
predictions of 0.53 to 0.58 for distant-metastases, but with
no improvement for local recurrence.
Pearce et al. Radiation exposure from CT scans in childhood and subse-
quent risk of leukaemia and brain tumours: a retrospective
cohort study
2012 This paper highlights the risk of high-dose CT imagery for
routine screening, primarily in children. While the absolute
risk of leukemia or brain cancer is small (74 and 135, re-
spectively, out of 176,000), a cumulative dose of 50-60 mSv
triples the baseline risk, indicating a need for low-dose CT
scans over riskier standard-dose scans. (For comparison, a
typical chest CT scan has a dose of about 8 mSv.)
12
Table 2.1 (Continued)
Author Title
Year Description
Miglioretti et al. The use of computed tomography in pediatrics and the as-
sociated radiation exposure and estimated cancer risk
2013 Pediatric CT imagery and its dosages and risks are studied
here. According to the authors, between 3% and 8% of
chest CT scans performed on patients between the ages of
birth and 15 years had an effective dose of 20 mSv or higher.
Pediatric CT scans are responsible for one solid cancer in
girls for every 330-480 chest scans; the risk is lower for boys
at 1,080-1,650 chest scans for each solid cancer. Reducing
the highest quartile of doses to the median could prevent
43% of the 4,870 predicted cancers caused by pediatric CT
scans each year.
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Table 2.1 (Continued)
Author Title
Year Description
Smith-Bindman et al. Radiation dose associated with common computed tomog-
raphy examinations and the associated lifetime attributable
risk of cancer
2009 The authors of this study examine the risk of cancer intro-
duced from CT examinations. The CT scans studied are of
more standard diagnostic dosages, ranging from 2 mSv for
head scans to 31 mSv for multiphase abdominal and pelvic
scans. Routine chest CTs had a median dosage of 8 mSv,
equivalent to 117-119 chest X-ray scans. An estimated 1 in
270 women and 1 in 600 men who undergo a routine chest
CT at age 40 will develop cancer due to that examination;
this risk doubles at age 20 and is reduced by half at age 60.
The authors suggest the use of lower and more standardized
doses.
Dhara et al. A Combination of Shape and Texture Features for Classifi-
cation of Pulmonary Nodules in Lung CT Images
2016 The authors use a similar methodology to that used in this
work, with a single time point. Specifically, they combine
shape and texture features with feature selection and tradi-
tional classification (specifically, support vector machines,
as opposed to a variety of algorithms used in this work).
Their classification is more nuanced, with five “levels of ma-
lignancy” (classes) instead of the binary benign/malignant
division used in our work.
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Table 2.1 (Continued)
Author Title
Year Description
Dilger et al. Improved pulmonary nodule classification utilizing quanti-
tative lung parenchyma features
2015 In this paper, the authors examine the use of features de-
rived from the CT imagery of the parenchyma (functional
tissue) immediately surrounding a specified lung nodule to
determine the malignancy of that nodule. The CT imagery
was derived from high-resolution (and therefore high-dose)
scans of 50 nodules; including parenchymal features im-
proved the classification AUC from 0.918 (nodule features
only) to 0.938 (including parenchymal features).
Van Elmpt et al. Response Assessment Using 18F-FDG PET Early in
the Course of Radiotherapy Correlates with Survival in
Advanced-Stage Non–Small Cell Lung Cancer
2012 The authors of this study examine the 18FDG-PET/CT
scans of 34 non-small-cell lung cancer patients before and
after two weeks of radiotherapy, using CT volume and stan-
dardized uptake value parameters to determine prognosis.
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CHAPTER 3
EXPERIMENTS
Several experiments were performed to determine the efficacy of change descriptors for lung
nodule classification.
3.1 National Lung Screening Trial, Delta Features
For this experiment, we used a subset of the low-dose CT imagery from the National Lung
Screening Trial (NLST)[24].
The NLST compared the effectiveness of low-dose CT imagery to that of traditional X-ray
chest radiography. Patients were at high risk of lung cancer; all patients were between the ages of
55 and 74 at the time they began participating in the study, and had been a smoker for at least 30
pack-years. If they were no longer smokers, then they were required to have quit within the 15 years
prior to the beginning of the study to be eligible to participate. 53,454 patients were enrolled, with
26,722 of them undergoing low-dose CT screening (where “low-dose” is an average effective dose
of 1.5 mSv, versus the approximately 8 mSv average effective dose delivered in a typical chest CT
screening) and the remainder undergoing posteroanterior chest radiography, either via screen-film
methods or digital methods.
Each patient was required to undergo up to three screenings. The first reading (‘time 0’),
was given shortly after the patient was randomly assigned to a group. Subsequent screenings (‘time
1’ and ‘time 2’) were at approximately one-year intervals afterward. Patients with a diagnosis of
lung cancer were not screened again after the diagnosis.
Of the group receiving low-dose CT scans, we focused on two pairs of cohorts. Cohort IC1
(“Incident Cohort 1”) were patients who had pulmonary nodules detected during the first screening
and in whom lung cancer was diagnosed from the second screening (‘time 1’) of the same nodule.
Cohort NC1 (“Non-incident Cohort 1”) were patients who had pulmonary nodules detected during
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all three screenings, but who were matched based on their attributes with the patients in cohort
IC1. Cohort IC2 were patients for whom nodules were detected during the first two screenings,
and cancer was diagnosed due to the third screening (‘time 2’). Cohort NC2 were patients, also
with pulmonary nodules in all three screenings, who were paired with the patients in cohort IC2
in the same way as with cohorts NC1 and IC1. We considered patients in cohorts IC1 and IC2
to be ‘positive’, and patients in cohorts NC1 and NC2 ‘negative’, for the purpose of classification.
This experiment was performed on a subset of these cohorts, patients for whom the imagery was
available and for whom the same nodules had been segmented across each screening. Due to the
labor-intensive nature of that process, there were 476 patients in these subsets: 77 in cohort IC1,
83 in cohort IC2, 172 in cohort NC1, and 144 in cohort NC2. Cohorts IC1 and NC1 were combined
to form “cohort 1” and cohorts IC2 and NC2 were likewise combined to form “cohort 2”.
Image features were extracted from the CT images with the Lung Tumor Analysis applica-
tion on the Definiens Developer XD c© platform. This yielded 219 features, listed in appendix A.
In addition to the full set of 219 features, classification was performed on three subsets:
1. NC1Stable: features which, on the readings of patients in cohort NC1, had a Concordance
Correlation Coefficient (CCC) of greater than 0.6; this indicates that the features are stable
across multiple readings and therefore less likely to be noise. This subset contained 37
features.
2. RiderC95: features which, when generated from the Reference Imaging Database to Eval-
uate Response (RIDER) image set, had a CCC of greater than 0.95 under both manual
segmentation and a one-click ensemble segmentation algorithm[15]. The RIDER data set
contains pairs of images taken fifteen minutes apart, a “test-retest” strategy, to make the
detection of noise in features more likely. This subset contains 23 features.
3. Volume: the “Volume [cm3]” feature considered by itself. This was intended to rule out the
possibility that just the change in volume was responsible for the improved results.
Each data set was split into three screenings: Diagnosis, the scan taken at the time of
diagnosis (time 1 for cohort 1 and time 2 for cohort 2); Prior, the scan taken approximately
one year prior to diagnosis (time 0 for cohort 1 and time 1 for cohort 2); and Delta, which is a
straightforward arithmetic difference of the Prior features from the Diagnosis features.
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The values in each feature were normalized by linearly scaling and offsetting the feature
values such that the range for each feature was [−1, 1] in cohort 1. The same scale and offset
were made to the corresponding feature in cohort 2, despite some of the resulting values ending up
outside the [−1, 1] range.
All classification was performed via the Weka[16] data mining suite.
The following classifiers were tried:
• Na¨ıve Bayes[19]
• J48 (C4.5 decision trees)[26]
• Random Forests[5] with 200 trees, selecting from log2(f) features each tree (where f is the
number of features)
• Support vector machines (LibSVM)[7], with C and γ tuned via grid search
– Linear kernel
– Radial basis function kernel
3.1.1 Results
For these datasets, guessing the majority class gives an accuracy of 65.16% (77 ‘positive’, 144
‘negative’). With only two exceptions, the listed classifiers gave an accuracy higher than guessing
the majority.
The highest accuracy, 83.71%, was from the NC1Stable feature subset, using the Random
Forests classifier with 15 features selected by CFS. In general, classification on the Delta screen-
ings gave higher accuracy than Diagnosis alone; this improvement was statistically significant as
determined by the Wilcoxon signed-rank test (p < 0.05). The exception is the volume-only data
set, as there were insufficient data for the test to be accurate.
In most cases, Random Forests outperformed the other classifiers; the improvement in
performance tends to increase as the number of features increases. Conversely, Random Forests
gave only mediocre performance on the Volume subset, as it only had one feature to work with.
Due to the need for a hyperparameter optimization step (executed via grid search on cost
and γ), the SVM classifiers were slower than the others by orders of magnitude. While they did
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Table 3.1 Accuracy and AUC for experiments on all features at single time points.
Delta
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 71.95% (0.704) 73.76% (0.622) 81.00% (0.825) 75.57% (0.731) 77.38% (0.764)
CFS 71.95% (0.705) 74.21% (0.634) 81.00% (0.826) 75.57% (0.731) 77.38% (0.764)
CFS (5) 78.73% (0.797) 80.54% (0.742) 77.38% (0.772) 76.02% (0.749) 77.83% (0.768)
CFS (10) 78.28% (0.804) 80.54% (0.742) 80.54% (0.807) 76.02% (0.751) 77.83% (0.807)
CFS (15) 78.28% (0.807) 80.54% (0.749) 81.45% (0.824) 78.28% (0.759) 80.09% (0.830)
CFS (20) 78.28% (0.788) 80.54% (0.749) 81.90% (0.840) 76.02% (0.725) 81.00% (0.810)
Relief-F (5) 75.11% (0.770) 76.47% (0.712) 73.30% (0.772) 74.66% (0.701) 74.66% (0.771)
Relief-F (10) 77.83% (0.782) 75.11% (0.666) 79.64% (0.787) 75.57% (0.704) 75.57% (0.795)
Relief-F (15) 78.73% (0.788) 76.92% (0.716) 79.19% (0.805) 76.92% (0.702) 76.92% (0.794)
Relief-F (20) 78.28% (0.787) 76.47% (0.710) 80.54% (0.806) 76.47% (0.712) 78.28% (0.810)
Diagnosis
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 77.83% (0.708) 76.47% (0.693) 79.19% (0.808) 77.38% (0.792) 75.57% (0.763)
CFS 77.83% (0.708) 76.02% (0.682) 77.38% (0.813) 77.38% (0.792) 75.57% (0.763)
CFS (5) 76.02% (0.759) 73.76% (0.669) 76.47% (0.788) 76.02% (0.759) 74.66% (0.752)
CFS (10) 76.02% (0.790) 71.04% (0.630) 78.28% (0.810) 75.11% (0.819) 75.57% (0.783)
CFS (15) 74.66% (0.746) 75.11% (0.704) 78.28% (0.815) 75.57% (0.818) 76.92% (0.769)
CFS (20) 74.66% (0.732) 74.21% (0.666) 78.73% (0.801) 75.57% (0.806) 74.66% (0.766)
Relief-F (5) 71.04% (0.747) 76.02% (0.715) 72.40% (0.776) 71.95% (0.741) 75.11% (0.789)
Relief-F (10) 73.30% (0.747) 71.04% (0.728) 75.11% (0.801) 76.47% (0.768) 77.83% (0.810)
Relief-F (15) 75.11% (0.714) 71.95% (0.681) 76.92% (0.790) 77.83% (0.780) 75.57% (0.758)
Relief-F (20) 76.02% (0.768) 71.95% (0.681) 75.57% (0.795) 77.38% (0.785) 78.28% (0.798)
Prior
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 69.23% (0.680) 66.97% (0.621) 73.30% (0.777) 71.49% (0.758) 69.68% (0.770)
CFS 69.23% (0.680) 66.52% (0.611) 72.85% (0.782) 71.49% (0.758) 69.68% (0.770)
CFS (5) 71.49% (0.649) 65.61% (0.638) 69.68% (0.732) 71.49% (0.660) 68.33% (0.686)
CFS (10) 73.30% (0.665) 67.42% (0.626) 73.30% (0.775) 71.49% (0.712) 71.49% (0.723)
CFS (15) 71.95% (0.690) 67.87% (0.611) 73.30% (0.767) 75.11% (0.757) 72.85% (0.752)
CFS (20) 72.40% (0.679) 69.23% (0.632) 72.40% (0.767) 74.21% (0.743) 72.40% (0.724)
Relief-F (5) 70.59% (0.723) 68.33% (0.645) 67.87% (0.739) 69.23% (0.677) 66.06% (0.707)
Relief-F (10) 67.87% (0.688) 69.23% (0.587) 70.59% (0.766) 70.59% (0.735) 71.95% (0.754)
Relief-F (15) 72.85% (0.722) 68.78% (0.561) 71.49% (0.803) 73.76% (0.687) 71.04% (0.718)
Relief-F (20) 69.68% (0.721) 69.23% (0.561) 73.76% (0.794) 74.21% (0.714) 73.76% (0.762)
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Table 3.2 Accuracy and AUC for experiments on the NC1Stable feature subset at single time points.
Delta
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 78.73% (0.758) 75.57% (0.671) 82.81% (0.818) 78.28% (0.736) 77.83% (0.730)
CFS 78.73% (0.758) 76.92% (0.719) 82.81% (0.811) 78.28% (0.736) 77.83% (0.730)
CFS (5) 77.38% (0.762) 80.54% (0.742) 79.19% (0.781) 74.66% (0.743) 77.38% (0.742)
CFS (10) 78.73% (0.788) 80.54% (0.749) 81.45% (0.809) 79.19% (0.770) 79.19% (0.816)
CFS (15) 78.73% (0.779) 78.73% (0.697) 83.71% (0.814) 78.73% (0.749) 78.73% (0.805)
CFS (20) 78.73% (0.795) 78.73% (0.697) 82.81% (0.828) 77.83% (0.750) 79.64% (0.784)
Relief-F (5) 76.92% (0.775) 76.02% (0.699) 76.92% (0.747) 79.19% (0.755) 75.11% (0.752)
Relief-F (10) 76.47% (0.776) 76.47% (0.694) 77.83% (0.769) 77.83% (0.737) 77.83% (0.723)
Relief-F (15) 78.28% (0.782) 76.02% (0.681) 78.28% (0.796) 77.83% (0.739) 78.28% (0.745)
Relief-F (20) 78.73% (0.792) 75.57% (0.655) 82.35% (0.822) 77.38% (0.743) 78.28% (0.774)
Diagnosis
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 78.73% (0.778) 75.11% (0.718) 79.19% (0.822) 76.47% (0.795) 76.47% (0.813)
CFS 78.73% (0.778) 75.57% (0.719) 78.28% (0.810) 76.47% (0.795) 76.47% (0.813)
CFS (5) 76.02% (0.825) 79.64% (0.741) 78.28% (0.765) 75.57% (0.814) 77.83% (0.806)
CFS (10) 76.47% (0.782) 80.09% (0.746) 78.28% (0.762) 76.47% (0.814) 79.64% (0.782)
CFS (15) 76.92% (0.802) 78.28% (0.734) 79.64% (0.785) 77.38% (0.811) 77.38% (0.788)
CFS (20) 78.73% (0.802) 77.38% (0.740) 79.19% (0.781) 77.83% (0.802) 78.73% (0.790)
Relief-F (5) 73.30% (0.771) 71.95% (0.691) 76.92% (0.774) 73.30% (0.782) 73.76% (0.769)
Relief-F (10) 76.02% (0.821) 70.59% (0.683) 74.66% (0.777) 72.85% (0.787) 74.21% (0.765)
Relief-F (15) 72.40% (0.823) 71.04% (0.690) 76.02% (0.809) 74.66% (0.822) 75.11% (0.828)
Relief-F (20) 78.73% (0.817) 78.73% (0.727) 79.19% (0.809) 78.28% (0.825) 73.76% (0.818)
Prior
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 73.76% (0.718) 67.87% (0.635) 74.21% (0.766) 69.23% (0.693) 71.95% (0.684)
CFS 73.76% (0.718) 70.14% (0.647) 73.76% (0.756) 69.23% (0.693) 71.95% (0.684)
CFS (5) 73.76% (0.658) 65.61% (0.645) 69.68% (0.706) 72.40% (0.633) 71.95% (0.632)
CFS (10) 71.49% (0.708) 65.61% (0.613) 73.30% (0.719) 70.14% (0.615) 70.14% (0.669)
CFS (15) 73.30% (0.691) 67.42% (0.601) 72.85% (0.744) 68.78% (0.605) 67.42% (0.619)
CFS (20) 72.85% (0.688) 67.42% (0.601) 74.21% (0.751) 70.14% (0.631) 67.87% (0.686)
Relief-F (5) 69.68% (0.647) 66.97% (0.550) 66.97% (0.681) 65.16% (0.578) 67.42% (0.694)
Relief-F (10) 68.33% (0.698) 66.97% (0.537) 73.76% (0.771) 67.42% (0.627) 72.85% (0.714)
Relief-F (15) 71.49% (0.769) 67.87% (0.678) 71.49% (0.762) 71.04% (0.648) 66.97% (0.716)
Relief-F (20) 72.85% (0.732) 68.33% (0.668) 73.76% (0.759) 71.49% (0.676) 71.95% (0.671)
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Table 3.3 Accuracy and AUC for experiments on the RiderC95 feature subset at single time points.
Delta
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 77.83% (0.777) 77.38% (0.733) 81.00% (0.820) 77.83% (0.810) 81.00% (0.809)
CFS 77.83% (0.777) 77.38% (0.733) 81.90% (0.836) 77.83% (0.810) 81.00% (0.809)
CFS (5) 77.38% (0.776) 77.83% (0.703) 78.73% (0.790) 74.66% (0.770) 76.92% (0.756)
CFS (10) 77.83% (0.786) 76.92% (0.709) 81.45% (0.808) 80.09% (0.798) 81.00% (0.808)
CFS (15) 77.83% (0.800) 77.38% (0.716) 82.35% (0.825) 78.28% (0.785) 80.09% (0.809)
CFS (20) 77.83% (0.797) 77.38% (0.716) 81.45% (0.815) 78.28% (0.793) 79.64% (0.786)
Relief-F (5) 76.47% (0.791) 77.38% (0.700) 81.00% (0.781) 77.38% (0.777) 81.00% (0.836)
Relief-F (10) 76.92% (0.798) 79.19% (0.737) 82.35% (0.811) 79.19% (0.807) 79.19% (0.815)
Relief-F (15) 77.38% (0.798) 77.38% (0.728) 81.90% (0.828) 78.28% (0.806) 79.19% (0.805)
Relief-F (20) 77.83% (0.790) 77.38% (0.728) 81.90% (0.808) 78.73% (0.794) 79.19% (0.795)
Diagnosis
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 77.38% (0.777) 75.11% (0.685) 80.54% (0.801) 80.09% (0.855) 79.19% (0.797)
CFS 77.38% (0.777) 74.21% (0.666) 80.54% (0.800) 80.09% (0.855) 79.19% (0.797)
CFS (5) 75.11% (0.829) 73.76% (0.740) 76.02% (0.765) 76.02% (0.828) 77.38% (0.810)
CFS (10) 75.57% (0.812) 75.11% (0.738) 78.28% (0.777) 77.38% (0.820) 77.83% (0.794)
CFS (15) 77.38% (0.767) 74.66% (0.739) 79.19% (0.788) 77.83% (0.824) 76.92% (0.786)
CFS (20) 77.38% (0.777) 75.57% (0.712) 79.19% (0.793) 79.19% (0.858) 79.64% (0.797)
Relief-F (5) 73.76% (0.798) 73.76% (0.725) 75.11% (0.781) 77.83% (0.817) 77.38% (0.800)
Relief-F (10) 77.83% (0.797) 73.76% (0.661) 77.83% (0.820) 78.73% (0.842) 80.09% (0.802)
Relief-F (15) 79.19% (0.789) 73.76% (0.636) 77.83% (0.814) 80.09% (0.847) 80.54% (0.802)
Relief-F (20) 77.38% (0.781) 75.57% (0.682) 78.28% (0.805) 80.09% (0.854) 80.09% (0.797)
Prior
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 75.57% (0.716) 66.52% (0.622) 72.85% (0.783) 76.92% (0.769) 76.92% (0.761)
CFS 75.57% (0.716) 68.33% (0.634) 73.76% (0.787) 76.92% (0.769) 76.92% (0.761)
CFS (5) 74.21% (0.708) 62.90% (0.599) 68.78% (0.722) 73.76% (0.677) 71.49% (0.669)
CFS (10) 76.47% (0.735) 66.97% (0.643) 73.30% (0.758) 74.21% (0.686) 72.85% (0.657)
CFS (15) 76.02% (0.763) 66.97% (0.660) 75.57% (0.781) 76.02% (0.760) 72.85% (0.798)
CFS (20) 75.57% (0.744) 69.23% (0.648) 76.47% (0.778) 76.92% (0.764) 74.66% (0.783)
Relief-F (5) 73.30% (0.736) 67.42% (0.688) 70.14% (0.746) 71.95% (0.733) 72.85% (0.728)
Relief-F (10) 75.11% (0.708) 68.33% (0.683) 73.76% (0.769) 76.02% (0.730) 74.66% (0.723)
Relief-F (15) 74.66% (0.718) 66.06% (0.650) 73.76% (0.789) 76.47% (0.768) 73.76% (0.792)
Relief-F (20) 74.66% (0.716) 66.52% (0.612) 74.21% (0.781) 76.02% (0.763) 76.02% (0.753)
21
Table 3.4 Accuracy and AUC for experiments on feature subset consisting solely of volume in cubic
centimeters at single time points.
Delta
Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
74.66% (0.768) 80.54% (0.763) 77.38% (0.798) 71.95% (0.738) 75.57% (0.775)
Diagnosis
Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
72.40% (0.779) 81.00% (0.758) 76.47% (0.725) 75.11% (0.751) 78.73% (0.750)
Prior
Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
71.04% (0.676) 67.42% (0.632) 69.68% (0.656) 73.76% (0.659) 72.85% (0.657)
provide the best performance in some cases (specifically, RiderC95 features with Prior data), the
improvement is unlikely to justify the runtime. This is offset, however, by the ease with which
the grid search process could be parallelized given a framework that supported it. As each point
in the grid search (at least without grid extension) is an independent classification, they could be
performed on different cores or different nodes with minimal difficulty.
3.2 National Lung Screening Trial, Delta Features With Single-Time Features
This experiment was an extension of the experiment described in section 3.1. The Prior,
Delta, and Diagnosis features were the same as in that experiment.
For this run, in addition to considering each set separately, we evaluated various classifiers on
two combinations of sets: Delta+Diagnosis and Prior+Delta+Diagnosis. The goal is to determine
whether combining single-time features with delta features could lead to improved performance
over delta features alone.
Feature subsets for each data set were combined. Hence, each subset had twice as many
features for Delta+Diagnosis and three times as many features for Prior+Delta+Diagnosis. Fea-
ture selection was performed with the same number of features; a feature selection algorithm that
retrieves 10 features retrieved 10 features no matter the input feature count. Again, the excep-
tion is Volume, as no feature selection was performed on it. However, feature selection could
have been performed, as there were two and three features, respectively, for Delta+Diagnosis and
Prior+Delta+Diagnosis. This was not explored as the feature selectors generally returned many
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more than three features. Also, other than the volume features from Prior and Delta, any other
combination of features has already been analyzed, so there is little point to investigating them
again.
3.2.1 Results
In general, combining both delta features and single-time features typically does not yield
significant benefits beyond simply using delta features. In fact, comparing Table 3.5 to Table 3.1,
Table 3.6 to Table 3.2, and Table 3.7 to Table 3.3 reveals that the addition of single-time features
to delta features tends to result in degraded performance relative to delta features on their own
with most classifiers and feature selectors tested.
For all features (Table 3.5), the combination of Delta and Diagnosis features resulted in an
accuracy of 81.00%, versus 81.90% for Delta alone. NC1Stable (Table 3.6) saw a smaller drop, from
83.71% with Delta alone to 83.26% with Delta and Diagnosis. The best result for the RiderC95
subset (Table 3.7) remains the same, at 82.35%.
For the volume subset, the addition of both Prior and Diagnosis features yield improved
performance: 81.90% versus 81.00% for Diagnosis alone or Delta with Diagnosis or 80.54% for Delta
alone. See Table 3.8.
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Table 3.5 Accuracy and AUC for experiments on all features at combinations of time points.
Delta+Diagnosis
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 75.57% (0.716) 69.68% (0.586) 80.09% (0.834) 75.57% (0.801) 76.47% (0.821)
CFS 75.57% (0.716) 73.76% (0.614) 81.00% (0.837) 75.57% (0.801) 76.47% (0.821)
CFS (5) 77.38% (0.777) 79.64% (0.756) 79.19% (0.803) 74.66% (0.763) 76.02% (0.737)
CFS (10) 78.28% (0.798) 78.73% (0.725) 79.19% (0.835) 76.47% (0.772) 76.92% (0.826)
CFS (15) 78.73% (0.781) 77.38% (0.679) 79.19% (0.830) 75.57% (0.782) 77.38% (0.797)
CFS (20) 77.38% (0.778) 75.11% (0.692) 78.73% (0.850) 77.83% (0.819)
Relief-F (5) 72.40% (0.661) 72.40% (0.698) 76.02% (0.784) 71.95% (0.687) 76.47% (0.758)
Relief-F (10) 72.40% (0.669) 70.59% (0.714) 77.38% (0.823) 71.95% (0.716) 71.95% (0.682)
Relief-F (15) 71.95% (0.671) 73.30% (0.673) 76.47% (0.813) 71.95% (0.752) 71.95% (0.683)
Relief-F (20) 71.95% (0.679) 74.21% (0.739) 76.02% (0.803) 72.40% (0.770) 71.95% (0.697)
Prior+Delta+Diagnosis
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 76.02% (0.717) 77.83% (0.745) 81.00% (0.840) 77.83% (0.838) 73.30% (0.757)
CFS 75.57% (0.712) 76.02% (0.753) 80.54% (0.836) 77.83% (0.838) 73.30% (0.757)
CFS (5) 77.38% (0.777) 79.64% (0.756) 79.19% (0.803) 74.66% (0.763) 76.02% (0.737)
CFS (10) 78.73% (0.801) 78.28% (0.715) 77.38% (0.836) 73.76% (0.764) 77.38% (0.837)
CFS (15) 79.19% (0.763) 76.02% (0.633) 79.19% (0.832) 75.11% (0.773) 76.92% (0.810)
CFS (20) 79.64% (0.774) 81.00% (0.741) 80.09% (0.844) 77.38% (0.806) 76.02% (0.791)
Relief-F (5) 71.95% (0.739) 71.04% (0.695) 76.02% (0.808) 71.95% (0.764) 71.95% (0.723)
Relief-F (10) 71.95% (0.703) 71.04% (0.648) 77.38% (0.797) 71.04% (0.762) 75.57% (0.766)
Relief-F (15) 71.95% (0.680) 70.14% (0.631) 77.83% (0.807) 71.95% (0.749) 71.95% (0.684)
Relief-F (20) 71.95% (0.699) 72.85% (0.695) 76.92% (0.808) 71.95% (0.782) 71.95% (0.772)
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Table 3.6 Accuracy and AUC for experiments on the NC1Stable feature subsets at combinations
of time points.
Delta+Diagnosis
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 78.28% (0.774) 77.83% (0.719) 81.45% (0.832) 80.09% (0.790) 81.00% (0.849)
CFS 78.28% (0.774) 78.28% (0.721) 81.90% (0.833) 80.09% (0.790) 81.00% (0.849)
CFS (5) 77.83% (0.757) 79.64% (0.756) 77.83% (0.804) 77.83% (0.791) 77.83% (0.774)
CFS (10) 79.19% (0.790) 81.00% (0.762) 79.64% (0.812) 77.38% (0.828) 78.28% (0.806)
CFS (15) 79.19% (0.795) 81.00% (0.740) 83.26% (0.832) 80.09% (0.786) 80.54% (0.790)
CFS (20) 78.28% (0.786) 79.64% (0.742) 82.35% (0.820) 81.00% (0.783) 82.35% (0.814)
Relief-F (5) 72.85% (0.720) 69.68% (0.583) 69.68% (0.715) 70.59% (0.724) 67.87% (0.666)
Relief-F (10) 73.30% (0.773) 71.95% (0.717) 76.02% (0.819) 74.66% (0.777) 77.83% (0.816)
Relief-F (15) 71.49% (0.748) 74.21% (0.729) 77.38% (0.802) 74.66% (0.750) 81.00% (0.806)
Relief-F (20) 74.21% (0.813) 68.78% (0.642) 79.19% (0.797) 77.38% (0.771) 76.92% (0.786)
Prior+Delta+Diagnosis
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 78.73% (0.768) 78.73% (0.672) 82.35% (0.832) 79.64% (0.791) 79.64% (0.856)
CFS 78.73% (0.768) 81.45% (0.715) 82.35% (0.849) 79.64% (0.791) 79.64% (0.856)
CFS (5) 76.92% (0.782) 78.73% (0.723) 78.73% (0.781) 76.92% (0.764) 76.92% (0.777)
CFS (10) 78.73% (0.787) 80.54% (0.744) 79.64% (0.821) 78.73% (0.813) 80.09% (0.816)
CFS (15) 79.19% (0.804) 82.35% (0.775) 82.81% (0.839) 81.45% (0.803) 81.90% (0.818)
CFS (20) 79.19% (0.812) 83.26% (0.798) 81.45% (0.833) 80.54% (0.804) 80.54% (0.820)
Relief-F (5) 69.68% (0.687) 67.42% (0.578) 69.68% (0.723) 69.23% (0.681) 67.42% (0.699)
Relief-F (10) 72.40% (0.803) 71.95% (0.687) 79.19% (0.798) 71.95% (0.793) 71.95% (0.794)
Relief-F (15) 72.40% (0.809) 71.95% (0.687) 76.92% (0.799) 72.40% (0.778) 71.95% (0.773)
Relief-F (20) 71.95% (0.809) 68.78% (0.653) 77.38% (0.806) 73.30% (0.712) 71.95% (0.755)
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Table 3.7 Accuracy and AUC for experiments on the RiderC95 feature subset at combinations of
time points.
Delta+Diagnosis
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 78.28% (0.778) 76.47% (0.711) 80.54% (0.842) 81.90% (0.834) 81.00% (0.805)
CFS 78.28% (0.778) 76.47% (0.711) 81.00% (0.847) 81.90% (0.834) 81.00% (0.805)
CFS (5) 78.73% (0.750) 81.00% (0.752) 78.73% (0.774) 76.47% (0.758) 76.47% (0.759)
CFS (10) 78.73% (0.822) 77.83% (0.721) 80.54% (0.816) 80.09% (0.829) 79.64% (0.821)
CFS (15) 78.28% (0.814) 76.92% (0.759) 80.54% (0.824) 79.64% (0.828) 80.09% (0.828)
CFS (20) 78.28% (0.809) 75.57% (0.732) 81.90% (0.830) 80.54% (0.815) 81.00% (0.821)
Relief-F (5) 77.38% (0.804) 74.21% (0.718) 77.38% (0.794) 76.92% (0.797) 78.28% (0.791)
Relief-F (10) 78.73% (0.820) 77.38% (0.672) 81.00% (0.834) 80.09% (0.859) 80.54% (0.821)
Relief-F (15) 78.73% (0.827) 76.47% (0.658) 80.09% (0.835) 81.45% (0.825) 81.00% (0.847)
Relief-F (20) 78.73% (0.812) 75.57% (0.642) 79.64% (0.818) 81.00% (0.825) 81.45% (0.866)
Prior+Delta+Diagnosis
Feat. Sel. Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
All Features 78.73% (0.769) 78.28% (0.700) 80.54% (0.845) 80.54% (0.827) 80.09% (0.814)
CFS 78.73% (0.769) 79.19% (0.732) 81.45% (0.843) 80.54% (0.827) 80.09% (0.814)
CFS (5) 78.73% (0.750) 81.00% (0.752) 78.73% (0.774) 76.47% (0.758) 76.47% (0.759)
CFS (10) 77.83% (0.812) 81.45% (0.759) 81.00% (0.823) 77.83% (0.818) 80.09% (0.824)
CFS (15) 78.73% (0.824) 76.92% (0.697) 81.00% (0.838) 81.00% (0.822) 81.90% (0.842)
CFS (20) 78.28% (0.821) 76.47% (0.728) 80.54% (0.835) 81.45% (0.819) 81.90% (0.870)
Relief-F (5) 79.19% (0.847) 74.66% (0.721) 76.02% (0.807) 78.73% (0.785) 78.73% (0.788)
Relief-F (10) 79.64% (0.824) 74.21% (0.727) 76.02% (0.820) 79.64% (0.808) 79.64% (0.822)
Relief-F (15) 79.19% (0.824) 76.47% (0.698) 76.92% (0.830) 82.35% (0.831) 80.54% (0.837)
Relief-F (20) 79.19% (0.825) 76.47% (0.724) 79.64% (0.832) 81.45% (0.832) 81.45% (0.805)
Table 3.8 Accuracy and AUC for experiments on feature subset consisting solely of volume in cubic
centimeters at combinations of time points.
Delta + Diagnosis
Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
75.11% (0.796) 81.00% (0.761) 77.83% (0.749) 76.02% (0.756) 80.09% (0.764)
Prior + Delta + Diagnosis
Na¨ıve Bayes J48 Random Forests SVM Linear SVM RBF
76.02% (0.793) 81.00% (0.761) 80.09% (0.761) 74.66% (0.755) 81.90% (0.792)
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CHAPTER 4
CONCLUSIONS
4.1 Results
With the data set and classifiers available, the highest accuracy increased from 81.00% to
83.71%, and the highest AUC increased from 0.858 to 0.859. The results are statistically significant,
though small, via the Wilcoxon signed-rank test (p < 0.05).
These results show that the introduction of change descriptors can, under certain circum-
stances, improve classification accuracy. While we would certainly have preferred a greater im-
provement, the technique can still be improved.
4.2 Future Directions
Several potential research directions can be obtained from this work.
The most obvious is to introduce more sophisticated descriptors, such as using a weighted
combination instead of a linear difference. These weights could be determined per-feature or a
single set of weights could be determined for the entire feature set, or could even be produced from
other features, to encode the relationships between them.
If more than two scans are available, the additional information could be used to determine
the acceleration of changes. For lung cancer, however, this is unlikely for at least the foreseeable
future as CT scans are both expensive and, ironically, increase the risk of cancer [25]. The National
Lung Screening Trial has shown that low-dose CT screening improves outcomes relative to chest
X-rays, but even low-dose CT screening introduces some risk; physicians are advised to limit the
number and dosage of CT screenings to the minimum necessary [11].
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APPENDIX A: DEFINIENS FEATURE LIST
Table A.1 All features and their subset membership.
Name NC1Stable? RiderC95? Volume?
Longest Diameter [mm] Yes Yes
Short Axis * Longest Diameter [mm ] Yes Yes
Short Axis [mm] Yes Yes
Mean [HU] Yes Yes
StdDev [HU] Yes
Volume [cm ] Yes Yes Yes
5a 3D MacSpic NumberOf Yes
8a 3D Is Attached To Pleural Wall Yes Yes
8b 3D Relative Border To Lung Yes Yes
8c 3D Relative Border To PleuralWall Yes Yes
8d 3D Ratio Free To Attached
9a 3D FractionalAnisotropy
9b 3D Circularity Yes
9c 3D Compactness Yes
9d 3D AV Dist COG To Border [mm] Yes
9e 3D SD Dist COG To Border [mm] Yes Yes
9f 3D MIN Dist COG To Border [mm] Yes
9g 3D MAX Dist COG To Border [mm] Yes Yes
10a 3D Relative Volume AirSpaces Yes
10b 3D Number AirSpaces Yes
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Table A.1 (Continued)
Name NC1Stable? RiderC95? Volume?
10c 3D Av Volume AirSpaces [mm ] Yes
10d 3D SD Volume AirSpaces [mm ]
Asymmetry Yes
Compactness Yes
Density
Elliptic Fit
Main direction
Radius of largest enclosed ellipse
Radius of smallest enclosing ellipse
Shape index Yes
Roundness Yes
Rectangular Fit
Area (Pxl) Yes
Volume (Pxl) Yes Yes
Number of pixels Yes Yes
Width (Pxl) Yes
Thickness (Pxl) Yes
Length (Pxl) Yes
Length/Thickness
Length/Width Yes
Border length (Pxl) Yes
avgCoocurrence-Homo
avgCoocurrence-MP
avgCoocurrence-contrast
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Table A.1 (Continued)
Name NC1Stable? RiderC95? Volume?
avgCoocurrence-energy
avgCoocurrence-entropy
avgCoocurrence-mean
avgGLN Yes
avgHGRE Yes
avgLGRE
avgLRE
avgLRHGE Yes
avgLRLGE
avgRLN Yes
avgRP Yes
avgSRE
avgSRHGE Yes
avgSRLGE
3D Laws features E5 E5 E5 Layer 1
3D Laws features E5 E5 L5 Layer 1 Yes
3D Laws features E5 E5 R5 Layer 1 Yes
3D Laws features E5 E5 S5 Layer 1
3D Laws features E5 E5 W5 Layer 1
3D Laws features E5 L5 E5 Layer 1
3D Laws features E5 L5 L5 Layer 1
3D Laws features E5 L5 R5 Layer 1
3D Laws features E5 L5 S5 Layer 1
3D Laws features E5 L5 W5 Layer 1
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Table A.1 (Continued)
Name NC1Stable? RiderC95? Volume?
3D Laws features E5 R5 E5 Layer 1
3D Laws features E5 R5 L5 Layer 1
3D Laws features E5 R5 R5 Layer 1
3D Laws features E5 R5 S5 Layer 1
3D Laws features E5 R5 W5 Layer 1
3D Laws features E5 S5 E5 Layer 1
3D Laws features E5 S5 L5 Layer 1
3D Laws features E5 S5 R5 Layer 1
3D Laws features E5 S5 S5 Layer 1
3D Laws features E5 S5 W5 Layer 1
3D Laws features E5 W5 E5 Layer 1
3D Laws features E5 W5 L5 Layer 1 Yes
3D Laws features E5 W5 R5 Layer 1
3D Laws features E5 W5 S5 Layer 1
3D Laws features E5 W5 W5 Layer 1
3D Laws features L5 E5 E5 Layer 1
3D Laws features L5 E5 L5 Layer 1
3D Laws features L5 E5 R5 Layer 1
3D Laws features L5 E5 S5 Layer 1
3D Laws features L5 E5 W5 Layer 1
3D Laws features L5 L5 E5 Layer 1
3D Laws features L5 L5 L5 Layer 1 Yes
3D Laws features L5 L5 R5 Layer 1
3D Laws features L5 L5 S5 Layer 1
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Table A.1 (Continued)
Name NC1Stable? RiderC95? Volume?
3D Laws features L5 L5 W5 Layer 1
3D Laws features L5 R5 E5 Layer 1
3D Laws features L5 R5 L5 Layer 1
3D Laws features L5 R5 R5 Layer 1
3D Laws features L5 R5 S5 Layer 1
3D Laws features L5 R5 W5 Layer 1
3D Laws features L5 S5 E5 Layer 1
3D Laws features L5 S5 L5 Layer 1
3D Laws features L5 S5 R5 Layer 1
3D Laws features L5 S5 S5 Layer 1
3D Laws features L5 S5 W5 Layer 1
3D Laws features L5 W5 E5 Layer 1
3D Laws features L5 W5 L5 Layer 1 Yes
3D Laws features L5 W5 R5 Layer 1
3D Laws features L5 W5 S5 Layer 1
3D Laws features L5 W5 W5 Layer 1
3D Laws features R5 E5 E5 Layer 1
3D Laws features R5 E5 L5 Layer 1
3D Laws features R5 E5 R5 Layer 1
3D Laws features R5 E5 S5 Layer 1
3D Laws features R5 E5 W5 Layer 1
3D Laws features R5 L5 E5 Layer 1
3D Laws features R5 L5 L5 Layer 1
3D Laws features R5 L5 R5 Layer 1
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Table A.1 (Continued)
Name NC1Stable? RiderC95? Volume?
3D Laws features R5 L5 S5 Layer 1
3D Laws features R5 L5 W5 Layer 1
3D Laws features R5 R5 E5 Layer 1
3D Laws features R5 R5 L5 Layer 1
3D Laws features R5 R5 R5 Layer 1
3D Laws features R5 R5 S5 Layer 1
3D Laws features R5 R5 W5 Layer 1
3D Laws features R5 S5 E5 Layer 1
3D Laws features R5 S5 L5 Layer 1
3D Laws features R5 S5 R5 Layer 1
3D Laws features R5 S5 S5 Layer 1
3D Laws features R5 S5 W5 Layer 1
3D Laws features R5 W5 E5 Layer 1
3D Laws features R5 W5 L5 Layer 1
3D Laws features R5 W5 R5 Layer 1
3D Laws features R5 W5 S5 Layer 1
3D Laws features R5 W5 W5 Layer 1
3D Laws features S5 E5 E5 Layer 1
3D Laws features S5 E5 L5 Layer 1
3D Laws features S5 E5 R5 Layer 1
3D Laws features S5 E5 S5 Layer 1
3D Laws features S5 E5 W5 Layer 1
3D Laws features S5 L5 E5 Layer 1
3D Laws features S5 L5 L5 Layer 1
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Table A.1 (Continued)
Name NC1Stable? RiderC95? Volume?
3D Laws features S5 L5 R5 Layer 1
3D Laws features S5 L5 S5 Layer 1
3D Laws features S5 L5 W5 Layer 1
3D Laws features S5 R5 E5 Layer 1
3D Laws features S5 R5 L5 Layer 1
3D Laws features S5 R5 R5 Layer 1
3D Laws features S5 R5 S5 Layer 1
3D Laws features S5 R5 W5 Layer 1
3D Laws features S5 S5 E5 Layer 1
3D Laws features S5 S5 L5 Layer 1
3D Laws features S5 S5 R5 Layer 1
3D Laws features S5 S5 S5 Layer 1
3D Laws features S5 S5 W5 Layer 1
3D Laws features S5 W5 E5 Layer 1
3D Laws features S5 W5 L5 Layer 1
3D Laws features S5 W5 R5 Layer 1
3D Laws features S5 W5 S5 Layer 1
3D Laws features S5 W5 W5 Layer 1
3D Laws features W5 E5 E5 Layer 1
3D Laws features W5 E5 L5 Layer 1
3D Laws features W5 E5 R5 Layer 1
3D Laws features W5 E5 S5 Layer 1
3D Laws features W5 E5 W5 Layer 1
3D Laws features W5 L5 E5 Layer 1
37
Table A.1 (Continued)
Name NC1Stable? RiderC95? Volume?
3D Laws features W5 L5 L5 Layer 1
3D Laws features W5 L5 R5 Layer 1
3D Laws features W5 L5 S5 Layer 1
3D Laws features W5 L5 W5 Layer 1
3D Laws features W5 R5 E5 Layer 1
3D Laws features W5 R5 L5 Layer 1
3D Laws features W5 R5 R5 Layer 1
3D Laws features W5 R5 S5 Layer 1
3D Laws features W5 S5 E5 Layer 1
3D Laws features W5 S5 L5 Layer 1
3D Laws features W5 R5 W5 Layer 1
3D Laws features W5 S5 R5 Layer 1
3D Laws features W5 S5 S5 Layer 1
3D Laws features W5 S5 W5 Layer 1
3D Laws features W5 W5 E5 Layer 1
3D Laws features W5 W5 L5 Layer 1
3D Laws features W5 W5 R5 Layer 1
3D Laws features W5 W5 S5 Layer 1
3D Laws features W5 W5 W5 Layer 1
Histogram Mean Layer 1
Histogram SD Layer 1
Histogram ENERGY Layer 1
Histogram ENTROPY Layer 1 Yes
Histogram KUR Layer 1
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Table A.1 (Continued)
Name NC1Stable? RiderC95? Volume?
Histogram SKEW Layer 1 Yes
3D Wavelet decomposition. P2 L2 C9 Layer 1
3D Wavelet decomposition. P1 L2 C9 Layer 1
3D Wavelet decomposition. P2 L2 C10 Layer 1
3D Wavelet decomposition. P2 L2 C11 Layer 1
3D Wavelet decomposition. P2 L2 C12 Layer 1
3D Wavelet decomposition. P2 L2 C13 Layer 1 Yes
3D Wavelet decomposition. P2 L2 C14 Layer 1 Yes
3D Wavelet decomposition. P2 L2 C15 Layer 1 Yes
3D Wavelet decomposition. P2 L2 C1 Layer 1
3D Wavelet decomposition. P2 L2 C2 Layer 1
3D Wavelet decomposition. P2 L2 C3 Layer 1
3D Wavelet decomposition. P2 L2 C4 Layer 1
3D Wavelet decomposition. P2 L2 C5 Layer 1
3D Wavelet decomposition. P2 L2 C6 Layer 1
3D Wavelet decomposition. P2 L2 C7 Layer 1
3D Wavelet decomposition. P2 L2 C8 Layer 1
3D Wavelet decomposition. P1 L2 C11 Layer 1
3D Wavelet decomposition. P1 L2 C10 Layer 1
3D Wavelet decomposition. P1 L2 C12 Layer 1
3D Wavelet decomposition. P1 L2 C13 Layer 1
3D Wavelet decomposition. P1 L2 C14 Layer 1
3D Wavelet decomposition. P1 L2 C15 Layer 1
3D Wavelet decomposition. P1 L2 C1 Layer 1
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Table A.1 (Continued)
Name NC1Stable? RiderC95? Volume?
3D Wavelet decomposition. P1 L2 C2 Layer 1
3D Wavelet decomposition. P1 L2 C3 Layer 1
3D Wavelet decomposition. P1 L2 C4 Layer 1
3D Wavelet decomposition. P1 L2 C5 Layer 1
3D Wavelet decomposition. P1 L2 C6 Layer 1
3D Wavelet decomposition. P1 L2 C7 Layer 1
3D Wavelet decomposition. P1 L2 C8 Layer 1
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APPENDIX B: COPYRIGHT PERMISSIONS
The permission below is for the use of material in chapters 1, 2, and 3, and appendix A.
Material appears from “Change descriptors for determining nodule malignancy in national
lung screening trial CT screening images”, by Benjamin Geiger, Samuel Hawkins, Lawrence O.
Hall, Dmitry B. Goldgof, Yoganand Balagurunathan, Robert A. Gatenby, and Robert J. Gillies,
published in SPIE Proceedings Vol. 9785: “Medical Imaging 2016: Computer-Aided Diagnosis”.
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